跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
澳广 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Amoxicillin and Dicloxacillin Sodium Capsules
Approved
化学药品
Amoxicillin and Dicloxacillin Sodium Capsules
澳美製藥廠有限公司
🇨🇳 National Medical Products Administration
Approval Date
May 23, 2025
Approval ID
81u8kAbpbwl
Company
澳美製藥廠有限公司
Type
化学药品
Approval Details
Approval Id
81u8kAbpbwl
Approval Number
国药准字HC20150024
Generic Name
阿莫西林双氯西林钠胶囊
Generic Name En
Amoxicillin and Dicloxacillin Sodium Capsules
Trade Name
澳广
Drug Type
化学药品
Dosage Form
胶囊剂
Strength
0.375g(C₁₆H₁₉N₃O₅S 0.25g与C₁₉H₁₇Cl₂N₃O₅S 0.125g)
Reg Date
2025-05-23
Expired Date
2030-05-22
Company Name
澳美製藥廠有限公司
Production Company Name
BRIGHT FUTURE PHARMACEUTICAL LABORATORIES LIMITED
Production Company Address
香港新界元朗工业村宏富街8号澳美制药中心
Company Detail Path
/organization/ao-mei-zhi-yao-chang-you-xian-gong-si
Production Company Detail Path
/organization/bright-future-pharmaceutical-laboratories-limited
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
May 23, 2025
Approval ID
81u8kAbpbwl
Type
化学药品
Back to NMPA Approvals